Zanubrutinib + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Coadministration increases zanubrutinib Cmax and AUC, which may increase the risk of BRUKINSA toxicities. Dose reduction recommended.
Mechanism
CYP3A inhibition increases zanubrutinib exposure
Source: NLP:zanubrutinib